Hearology®
Research

Door opens to gene therapy for hearing loss

The Aussie Ear Bank is a new genetic biobank for hearing loss. What it stores, how gene therapy research is progressing, and what it means for you now.

Written by
HearologyThe Hearology team
Medically reviewed by
Vincent HowardBSc (Hons), CECP, HCPC registered
Published20 May 2025
Updated17 November 2026
Read time4 min
Illustration of a cell with DNA strands
On this page ▾

Key takeaways

  • The Aussie Ear Bank is a research resource holding genetic samples and hearing test data.
  • Around half or more of hearing loss present from birth is genetic.
  • Gene therapy for hearing loss is still at trial stage and works only for specific genetic causes.
  • You can book a hearing test now if you are worried about changes in your hearing.

The Aussie Ear Bank is a genetic biobank for hearing loss, launched in Western Australia, that stores genetic samples and hearing test results so researchers worldwide can study why some people lose their hearing earlier or more severely than others1. It is a research resource, not a treatment, and gene therapies for hearing loss are still at trial stage.

What is the Aussie Ear Bank?

The Aussie Ear Bank, officially the Australasian Hearing Registry and Biobank, collects and stores genetic samples, hearing test results and other assessments from people with hearing loss. It is based at the Ear Science Institute Australia and is funded by a A$500,000 Future Health Research and Innovation grant, a A$150,000 grant from the Ian Potter Foundation and donations1,2.

The registry is designed to link with national and international databases, so clinicians, hospitals and geneticists in other countries can use it too.

Why is genetics a missing piece in hearing loss?

The World Health Organization projects that nearly 2.5 billion people will live with some degree of hearing loss by 20503. Noise, ageing and illness explain many cases, but many others have no clear cause, and genetics is increasingly seen as part of the answer.

“Everyone loses their hearing,” said Vincent Howard, Co-founder and Clinical Audiologist at Hearology. “But some of us lose it faster than others, and with no discernible cause. So it makes sense that genetics is a factor, and it will be fascinating to follow the work of and findings from this Australian hearing biobank.”

Around half or more of congenital (present from birth) hearing loss is genetic1. Researchers also see growing evidence that genes play a part in hearing loss that starts in middle age or later. “The emerging research around the world is that genetics is the big new factor in middle age and older people’s hearing loss,” said Professor Marcus Atlas, founder of Ear Science Institute Australia2.

If hearing loss runs in your family, or you have noticed changes with no obvious reason, you are not alone, and a hearing test is a simple way to see where you stand.

What have gene therapies achieved so far?

In 2023 a boy aged 11 in Philadelphia, born with profound hearing loss caused by a fault in a single gene (OTOF), received an experimental gene therapy in a clinical trial. About four months later he had mild to moderate hearing loss in the treated ear4. This is one case from an early-stage trial, and it applies only to this specific genetic cause.

The Aussie Ear Bank aims to build the data that research like this depends on: a large dataset of genetic samples, audiometric results (tests of how well a person hears sounds of different pitches and volumes) and other assessments that researchers can access worldwide1.

In time, this kind of data may help clinicians tailor care to a person’s genetic profile and better predict how their hearing may change. Whether it can slow or reverse any form of hearing loss is still being tested.

For more on this research, see our reports on gene therapy in congenital deafness and an early safety trial for childhood deafness.

Who is behind the biobank?

The biobank is led by Ear Science Institute Australia and built around collaboration. “Ear Science is proud to lead Australia with the first hereditary hearing loss biobank for the nation,” said the organisation’s CEO, Sandra Bellekom2.

The team sees the project as part of a wider global effort to understand the biological causes of hearing loss, with international institutions expected to contribute to and draw from the data.

What does this mean for hearing care today?

Personalised gene therapies are still in development, so nothing changes in the clinic yet. What the biobank offers is the groundwork: better data on why hearing changes, which may in time shape earlier diagnosis and more targeted care.

For now, the practical step is the same for everyone. If you are worried about your hearing, a hearing test will show whether there is a measurable change and what could help.

Share this article
Struggling to follow conversations?

Check your hearing for free

A free hearing screening with a clinician, who explains your results in plain English.

Book nowRead more
  • Same-day availability
  • Results explained in plain English

Frequently asked questions

Can hearing loss be genetic?
Yes. Around half or more of hearing loss present from birth is genetic, and researchers think genes also play a part in hearing loss that starts later in life. If it runs in your family, a hearing test can show where you stand.
Is there a gene therapy for hearing loss?
Not as a routine treatment. Gene therapies are in clinical trials, and early results apply only to specific single-gene causes, such as OTOF. Ask a GP or audiologist if you think a genetic cause may apply to you.
What is the Aussie Ear Bank?
It is a research biobank in Western Australia that stores genetic samples and hearing test data from people with hearing loss. Researchers worldwide can use it to study why hearing changes. It does not offer treatment.

References:

  1. [1] Ear Science Institute Australia, "Introducing the Aussie Ear Bank," Ear Science Institute Australia. Accessed: Nov. 16, 2026. [Online]. Available:
  2. [2] Hearing Review, "Ear Science Institute Australia developing biobank to advance genetic therapies for hearing loss," Hearing Review. Accessed: Nov. 16, 2026. [Online]. Available:
  3. [3] World Health Organization, "Deafness and hearing loss," WHO fact sheet. Accessed: Nov. 16, 2026. [Online]. Available:
  4. [4] Children's Hospital of Philadelphia, "Children's Hospital of Philadelphia performs first U.S. gene therapy procedure to treat genetic hearing loss," CHOP news release. Accessed: Nov. 16, 2026. [Online]. Available:
From Hearology
A grandmother reading with a child.

Missing what the little ones say?

Hearing screening
Book a hearing screening
Author
Written by HearologyThe Hearology team
Medically reviewed by
Vincent HowardBSc (Hons), CECP, HCPC registeredCo-founder & Clinical AudiologistReviewed 20 May 2025
Keep reading

More in Research

ResearchStudy links ADHD listening difficulties to brain networks3 min read
ResearchDB-OTO gene therapy for inherited deafness: what the trial found3 min read
ResearchBrain-inspired tech could transform hearing in noisy places3 min read
More Research articles →